Mupironasal (Mupirocin Calcium)

Mupirocin calcium, the active ingredient in Mupironasal, is a monocarboxylic acid antibiotic presented as a nasal ointment for nasal use. It is used to eradicate nasal carriage of Staphylococcus aureus, including MRSA, and to prevent postoperative Staphylococcal infections.

GNH USA supplies Mupironasal as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mupironasal is a topical antibiotic indicated for conditions involving Staphylococcus aureus colonisation and infection risk.

- Nasal carriage of Staphylococcus aureus (including MRSA): eradicates colonising bacteria to reduce infection risk. - Postoperative Staphylococcal infections: prevents infection after surgical procedures by decolonising the nasal passages. - Healthcare-associated transmission: lowers the chance of spreading Staphylococcus aureus among patients and staff.

Mupironasal may cause local or systemic reactions, although most users experience only mild effects.

Common Side Effects: - Nasal irritation: mild burning or stinging at the application site. - Itching: localized pruritus within the nostrils. - Dryness: reduced moisture of the nasal mucosa. - Crusting: formation of small crusts after repeated use.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or hives indicating hypersensitivity. - Severe nasal ulceration: painful lesions requiring medical attention. - Anaphylaxis: rare systemic reaction with breathing difficulty and hypotension. - Systemic infection: unlikely but reported in immunocompromised patients.

Before using Mupironasal, consider the following safety measures. - Pregnancy: consult a healthcare provider as safety data are limited. - Breastfeeding: discuss potential risks with a clinician before use. - Allergy: avoid if known hypersensitivity to mupirocin or calcium salts exists. - Duration of use: limit application to the prescribed period to minimise resistance development. - Application site: apply only to intact nasal mucosa; avoid eyes, mouth, and broken skin. - Store at room temperature: keep in the original tube, protect from moisture and heat.

Mupironasal has a low potential for drug‑drug interactions, but certain combinations warrant caution.

Major Interactions (Avoid): - Concurrent use with other topical antibiotics targeting the same organisms: may promote resistance. - Systemic antibiotics with overlapping spectrum: could reduce overall efficacy.

Moderate Interactions (Monitor Closely): - Use with nasal decongestant sprays: may alter local absorption. - Co‑administration with immunosuppressants: increased risk of secondary infections. - Application alongside other intranasal medications: assess for additive irritation.